October 2025
The global E-pharmacy market size is estimated at US$ 96.94 billion in 2024, is projected to grow to US$ 112.91 billion in 2025, and is expected to reach around US$ 435.82 billion by 2034. The market is projected to expand at a CAGR of 16.44% between 2025 and 2034.
The E-pharmacy market is growing because of the increasing internet penetration, smartphone usage, and rising demand for contactless and convenient medical care services. Strong presence of e-players such as 1mg, Netmeds, and Amazon pharmacy. Growing advancements in technology and telemedicine integration, and supportive government policies are driving the growth of the market.
Table | Scope |
Market Size in 2025 | USD 112.91 Billion |
Projected Market Size in 2034 | USD 435.82 Billion |
CAGR (2025 - 2034) | 16.44% |
Leading Region | North America |
Market Segmentation | By Drug Type, By Region |
Top Key Players | CVS Health, Optum Rx, Inc., Rowlands Pharmacy, DocMorris (Zur Rose Group AG), Cigna Corporation (Express Scripts Holdings), Amazon.com Inc., Axelia Solutions (Pharmeasy), Apex Healthcare Berhad (Apex Pharmacy), Apollo Pharmacy, Netmeds |
Increasing access to the internet and smartphones means the E-pharmacy market is rising, with consumer preference for online consumption and a growing focus on convenience. Growing adoption of digital technologies and e-commerce in the medical care sector. E-pharmacy, or mail-order pharmacy, is a pharmacy that operates over the Internet and sends orders to customers. Continue to grow post-pandemic, significantly owing to growing adoption by consumers due to the affordability, convenience, and accessibility offered by these platforms. The growing geriatric population is expected to fuel the growth of the market.
Increasing government initiative related to e-pharmacy in the healthcare sector, which drives the growth of the market.
For Instance,
Increasing adoption of digital technology in healthcare services contributes to the growth of the market.
For Instance,
E-pharmacy | Investment |
Truemeds | In March 2025, the Indian online pharmacy Truemeds closed a Series C funding round worth $44 million. |
MyDawa | The Kenyan online medical care platform MyDawa secured $20 million in Series B funding in May 2025. |
Apollo 24/7 | Raised $300 million (₹2,475 Cr) from Advent International private equity in 2024, at a valuation of $1.75 billion (₹14,478 Cr). |
In the drug type, the prescription drug segment led the E-pharmacy market, as online prescriptions often provide good pricing, discounts, and generic substitutes, leading to significant expense savings for patients. This type of platform enables consumer to browse and buy medications inconspicuously from the comfort of their own home, without the requirement for face-to-face communications. Realising e-prescriptions enhance productivity, reduce medication challenges, and improve convenience.
On the other hand, the OTC drug segment is projected to experience the fastest CAGR in the E-pharmacy market from 2025 to 2034, as it is evident that the greater use of OTC drugs enhances access, convenience, service, health results, and patient satisfaction. By offering a suitable opportunity for accessing drugs, online pharmacies contribute to enhancing healthcare results and lowering inequalities in access to crucial treatments. By working in a digital space, these stages often have lower overhead expenses as compared to brick-and-mortar pharmacies.
North America was dominant in the market in 2024, due to growing high internet and smartphone penetration. For instance, around 77% of its population uses a smartphone, so it has a massive consumer base that is happy with digital platforms and online spending. Healthcare providers transformed patient care with AI-driven automation, and huge digital infrastructure forms the backbone of any thriving health-tech hub in North America, which drives the growth of the market.
For Instance,
In September 2025, Novartis announced the launch of a direct-to-patient (DTP) platform in the US, which offers cash-paying patients prescribed Cosentyx the option to purchase it at a 55% discount off the list price. Cosentyx, Novartis’ top-selling product in the US, is a biologic that is FDA-approved for the treatment of multiple immune-mediated inflammatory diseases, including psoriasis, hidradenitis suppurativa, and psoriatic arthritis.
In March 2025, Phoenix, Canada’s foremost online health clinic for men, today announced it has signed a CAD 50 million Series A financing round. The round is led by Valspring Capital, with transformed investment from Y Combinator, and support from CIBC Innovation Banking. Phoenix is becoming a dominant force in digital healthcare, addressing long-standing gaps in access to treatment.
Asia Pacific is the fastest-growing region in the E-pharmacy market in the forecast period, due to the large and growing consumer base, the presence of huge populations, increasing disposable incomes, and a burgeoning middle class. Major e-pharmacy companies in this region started tie-ups with medical insurers to offer medicines to the consumer at lower prices, in turn saving the expenses for insurers. Consumers in the Asia-Pacific are progressively comfortable with e-commerce, and this preference for digital shopping spreads to healthcare, which drives the growth of the market.
For Instance,
In July 2025, Chinese tech giant Alibaba Group is seeking to raise around HK$12 billion ($1.53 billion) through exchangeable bonds to boost investments in its cloud infrastructure and global commerce operations. Investors later exchange these bonds, which link to Alibaba Health Technology, opens a new tab, for shares in Alibaba Health, and the bonds will not pay interest for a longer time.
In September 2025, Quick medicine delivery startup Plazza raised USD 1.4 million in a seed funding round led by All in Capital, with participation from Better Capital, Tracxn founder Abhishek Goyal, Bounce co-founder Vivekananda Hallekere, the Singhania family office, and the promoters of JK Tyre. Plazza operates on an omnichannel platform combining app-based ordering with physical outlets.
Europe is expected to grow significantly in the E-pharmacy market during the forecast period, as it has a vigorous and digitizing healthcare system and favorable government reforms, which increase the demand for e-pharmacy services in this region. As the growing load of chronic disease and medical care spending places growing pressure on health systems, a digital health revolution is needed to ensure the sustainability of European healthcare, which drives the growth of the market.
In July 2025, Redcare Pharmacy’s CardLink solution for e-Rx redemption was extended by Gematik, enabling a smooth transition to the next-generation technology. Redcare’s CardLink solution has been available in the Shop Apotheke app since May 2024, allowing patients in Germany to redeem their prescriptions digitally.
By Drug Type
By Region
October 2025
October 2025
October 2025
October 2025